Showing results (371-380 of 831) with videos related to

Sort By:
Pageof 84
British Journal of Haematology|October 4, 2007
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemiaKami Maddocks-Christianson, Susan L Slager, Clive S Zent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemiaGrzegorz S Nowakowski, James D Hoyer, Tait D Shanafelt, et al.
British Journal of Haematology|February 16, 2008
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potentialTait D Shanafelt, Susan M Geyer, Nancy D Bone, et al.
British Journal of Haematology|April 1, 2008
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphomaClive S Zent, Wei Ding, Susan M Schwager, et al.
Scientific Reports|April 16, 2021
Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemiaShulan Tian, Henan Zhang, Pan Zhang, et al.
Cancer Research|February 7, 2002
Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group studyRafael Fonseca, David Harrington, Martin M Oken, et al.
Cancer|October 2, 2009
Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalitiesFarhad Ravandi, Jean-Pierre Issa, Guillermo Garcia-Manero, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 12, 2011
The clinical significance of achieving different levels of cytogenetic response in patients with chronic phase chronic myeloid leukemia after failure to front-line therapy: is complete cytogenetic response the only desirable endpoint?Jorge Cortes, Alfonso Quintas-Cardama, Elias Jabbour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2010
The combination of a histone deacetylase inhibitor with the Bcl-2 homology domain-3 mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagyYue Wei, Tapan Kadia, Weigang Tong, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2013
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicinPartow Kebriaei, Kaci Wilhelm, Farhad Ravandi, et al.
Pageof 84